logo
logo
  • Home
  • About us
  • Story
  • Team
  • Our Approach
  • Careers
  • News
  • Contact
  • Investor Relations
  • PL
  • EN
      • Home
      • News

      News

      • Captor Therapeutics to attend the 11th Annual LifeSci Partners Corporate Access Event
        15.12.2021
        Captor Therapeutics to attend the 11th Annual LifeSci Partners Corporate Access Event
        more
      • Captor Therapeutics Presents 3Q’21 Financial Results and Provides a Business Update
        01.12.2021
        Captor Therapeutics Presents 3Q’21 Financial Results and Provides a Business Update
        more
      • Captor Therapeutics is one of the founders of the BioInMed - Polish Association of Innovative Medical Biotechnology Companies
        08.11.2021
        Captor Therapeutics is one of the founders of the BioInMed - Polish Association of Innovative Medical Biotechnology Companies
        more
      • Captor Therapeutics to Present at the 4th Annual Targeted Protein Degradation Summit
        26.10.2021
        Captor Therapeutics to Present at the 4th Annual Targeted Protein Degradation Summit

        Dr. Michał Walczak will present on 28 October 2021

        more
      • Captor Therapeutics presents H1 2021  financial results and provides business update
        15.10.2021
        Captor Therapeutics presents H1 2021 financial results and provides business update

        Captor presented data from its H1 2021 report during the WSE Innovation Day

        more
      • GPW Innovation Day
        11.10.2021
        GPW Innovation Day

        Captor Therapeutics will be present during upcoming Warsaw Stock Exchange Innovation Day

        more
      • Zaproszenie na spotkanie z przedstawicielami Spółki
        06.10.2021
        Zaproszenie na spotkanie z przedstawicielami Spółki
        celem prezentacji i omówienia wyników finansowych za okres H1 2021.
         
        more
      • Captor Therapeutics reveals pipeline project targeting the undrugged target MCL-1
        28.09.2021
        Captor Therapeutics reveals pipeline project targeting the undrugged target MCL-1

        The Company today announced key preclinical data and revealed the identity of the drug target

        more
      • Captor Therapeutics to Present at the 3rd European Protein Degradation Congress in September
        14.09.2021
        Captor Therapeutics to Present at the 3rd European Protein Degradation Congress in September

        Dr. Tom Shepherd will present on 21st September, 2021

        more
      • Collaboration with LifeSci Advisors
        30.08.2021
        Collaboration with LifeSci Advisors

        Captor Therapeutics S.A. has entered into an agreement with LifeSci Advisors LLC

        more
      • 1
      • 2
      • 3
      • 4
      • 5

      © 2018 Captor Therapeutics All rights reserved

      Design and implementation: Artneo.pl